UDG Healthcare plc Financials

Market Capitalization £2.72 Billion as of Aug. 1, 2021

Valuations Metrics as of Jan. 25, 2025

Trailing PE	42.48
Forward PE	20.75
Price to Sales TTM	£2.18
Price to Book MRQ	£262.47
Enterprise to Revenue	2.30
Enterprise to EBITDA	14.83

Financial Reports as of Sep. 30, 2020

Financials

Fiscal Year Ends	2020-09-30
Most Recent Quarter	2020-09-30
Profit Margin	7.13%
Operating Margin	11.12%
Return on Assets TTM	4.91%
Return on Equity TTM	8.98%

Income Statement

Revenue TTM	£1,246,968,960
Revenue per Share TTM	£4.96
Quarterly Revenue Growth	-4.60%
Gross Profit TTM	£398,171,000
EBITDA	£228,379,000
Net Income to Common TTM	£88,912,000
Diluted EPS TTM	£25.40
Quarterly Earnings Growth YoY	-7.10%

Balance Sheet

Total Cash MRQ	£230,479,008
Total Cash per Share MRQ	£0.92
Total Debt MRQ	£
Total Debt to Equity MRQ	36.63
Current Ratio MRQ	1.91
Book Value per Share MRQ	£4.11

Cash Flow

Operating Cash Flow TTM	£219,666,000
Levered Free Cash Flow TTM	£185,773,120

UDG Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	251,883,008
Float Shares	250,859,669
Avg 10 Volume	0
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.34%
% Held by Institutions	60.41%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	£10.77
Fifty Two Week High	£1099.00
Fifty Two Week Change	-0.98%
Day 50 MA	£891.58
Day 200 MA	£896.50

Dividends and Splits

Forward Annual Dividend Rate	£0.13
Forward Annual Dividend Yield	1.17%
Trailing Annual Dividend Rate	£0.13
Trailing Annual Dividend Yield	0.01%
Payout Ratio	48.34%
Dividend Date
Ex Dividend Date	2021-01-07
Last Split Factor
Last Split Date